Global Triple-Negative Breast Cancer Market Growth Propelled by Rapid Technological Advancements in Biopsy Techniques

April 12, 2023 | Healthcare

According to the latest report by IMARC Group, titled “­­Triple-Negative Breast Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033,” the global triple-negative breast cancer market size is witnessing steady growth. Triple-negative breast cancer (TNBC) refers to a specific type of aggressive breast cancer that tends to grow and spread quickly and is more challenging to treat. It tests negative for the three most common types of receptors found in breast cancer cells: estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2 (HER2). Due to this, it is not responsive to standard hormone therapy and certain targeted therapies. The signs of TNBC are similar to other forms of breast cancer, such as the formation of lumps or nodules, swelling in the breast, a dimpled or sagging appearance of the skin, discomfort in the breast or nipple, discharge from nipples, and inverted nipples. It can be diagnosed by mammography, biopsy, or other tests, such as magnetic resonance imaging (MRI), ultrasound, computational tomography, and positron emission tomography (PET) scans, and some common treatment options include surgery, chemotherapy, and radiation therapy. 

Global Triple-Negative Breast Cancer Market Trends:

The rising prevalence of breast cancer among women under age 40 and the increasing rate of reoccurrences are the key factors driving the market growth. Besides this, the advent of advanced biopsy techniques, which can be used for prognosis prediction, early relapse detection, and long-term disease tracking and treatment response, are providing lucrative opportunities for the market. Moreover, the widespread employment of nanotechnology for the clinical management of the disease, as it allows for the efficient delivery of drugs and agents to tumor sites, is propelling the market growth. Concurrently, innovative technological improvements in oncology therapeutics have shifted the focus towards an outcome-based approach to cancer care, which is creating a positive outlook for the market. In addition to this, ongoing biotechnological advancements, such as classifying TNBC into different subtypes based on messenger RNA (mRNA) expression profiles and unique tumor signatures, to generate information on actionable therapeutic targets, molecular drivers, and effective therapy selection is influencing the market growth. Furthermore, extensive investments by leading market players into research and development (R&D) initiatives for engineering accurate and high-resolution prognostic molecular biomarkers to distinguish high-risk residual TNBC tumors from low-risk ones are aiding in market expansion. 

Market Summary:

  • Region-wise, the market has been classified into the United States, EU5 (Germany, France, the United Kingdom, Italy, and Spain), and Japan. The United States has the largest patient population for triple-negative breast cancer and also represents the largest market for its treatment among the seven major markets.
  • This research study also offers a thorough overview of late-stage pipeline candidates and currently marketed medications for triple-negative breast cancer.
  • The study also offers a thorough overview of the treatment practices for triple-negative breast cancer, the share of specific therapies, and the performance of key market players.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Triple-Negative Breast Cancer Market Growth Propelled by Rapid Technological Advancements in Biopsy Techniques
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More